ÂÜÀòÂÒÂ×

Danielle Drachmann is a Senior Patient Partnering Manager at Evidera, PPD, Thermo Fisher Scientific, where responsibilities include building multi-stakeholder relationships and advancing patient engagement in clinical research. As CEO of Ketotic Hypoglycemia International, Drachmann unites families affected by unexplained ketotic hypoglycemia with leading medical experts, emphasizing co-creation and patient empowerment. Drachmann serves as a research committee member at the H. C Andersens Children's Hospital and a patient representative at the European Medicines Agency. Involvements include being a member of the Telemedicine and Patient-Centred Care Committee of the European Health Parliament, a Rare2030 Young Citizen with EURORDIS, and a guest researcher at the University of Southern Denmark focusing on user perspectives. Drachmann also participates in the European Health Futures Forum and the User Advisory Board at Gravitate Health. Educational background includes a Master's degree in Anthropology of Health from the University of Copenhagen and a Bachelor's degree in Social Education from VIA University College.